These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25744741)

  • 1. Cardiological aspects of stroke prevention.
    Fisher M; McAllister M
    Circ J; 2015; 79(2):271-7. PubMed ID: 25744741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials.
    Renda G; di Nicola M; De Caterina R
    Am J Med; 2015 Sep; 128(9):1007-14.e2. PubMed ID: 25910790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effective, safe stroke prevention with novel oral anticoagulants in patients with atrial fibrillation. Focus on dabigatran].
    Szapary L; Fehér G; Bosnyák E; Deli G; Csécsei P
    Ideggyogy Sz; 2013 May; 66(5-6):165-74. PubMed ID: 23909016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of cardioembolic stroke in patients with atrial fibrillation.
    Weber R; Diener HC; Weimar C
    Expert Rev Cardiovasc Ther; 2010 Oct; 8(10):1405-15. PubMed ID: 20936927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal trends in ischemic stroke and anticoagulation therapy among Medicare patients with atrial fibrillation: a 15-year perspective (1992-2007).
    Shroff GR; Solid CA; Herzog CA
    JAMA Intern Med; 2013 Jan; 173(2):159-60. PubMed ID: 23266657
    [No Abstract]   [Full Text] [Related]  

  • 6. Atrial Fibrillation for the Neurologist: Preventing both Ischemic and Hemorrhagic Strokes.
    Gokcal E; Pasi M; Fisher M; Gurol ME
    Curr Neurol Neurosci Rep; 2018 Feb; 18(2):6. PubMed ID: 29411147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous devices for stroke prevention.
    Bayard YL; Ostermayer SH; Hein R; Skowasch M; Büscheck F; Baranowski A; Heinisch C; Sievert H
    Cardiovasc Revasc Med; 2007; 8(3):216-25. PubMed ID: 17765654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current approaches to anticoagulation for reducing risk of atrial fibrillation-related stroke.
    Sanoski CA
    J Pharm Pract; 2013 Jun; 26(3):204-13. PubMed ID: 22842506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticoagulant treatment in patients with atrial fibrillation, according to risk factors for stroke].
    Lamy C; Mas JL
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Dec; 11(1 Suppl):23-33. PubMed ID: 24463061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel oral anticoagulants in secondary prevention of stroke.
    Diener HC; Easton JD; Hankey GJ; Hart RG
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):131-9. PubMed ID: 23953901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation.
    Yu HC; Tsai YF; Chen MC; Yeh CH
    Int J Stroke; 2012 Feb; 7(2):112-7. PubMed ID: 22103748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic and nonpharmacologic therapies for stroke prevention in nonvalvular atrial fibrillation.
    Han J; Cheng J; Mathuria N
    Pacing Clin Electrophysiol; 2012 Jul; 35(7):887-96. PubMed ID: 22452616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel oral anticoagulants in non-valvular atrial fibrillation.
    Potpara TS; Lip GY
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):115-29. PubMed ID: 23953900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
    Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation: stroke prevention in focus.
    Ferguson C; Inglis SC; Newton PJ; Middleton S; Macdonald PS; Davidson PM
    Aust Crit Care; 2014 May; 27(2):92-8. PubMed ID: 24054541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulants in patients with atrial fibrillation and end-stage renal disease.
    Brimble KS; Ingram AJ; Eikelboom JW; Hart RG
    Postgrad Med; 2012 Nov; 124(6):17-25. PubMed ID: 23322135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment strategies for prevention of cardioembolic stroke in atrial fibrillation.
    Park JW; Leithäuser B; Rittger H; Brachmann J
    Clin Hemorheol Microcirc; 2010; 46(4):251-64. PubMed ID: 21187574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion.
    Lewalter T; Kanagaratnam P; Schmidt B; Rosenqvist M; Nielsen-Kudsk JE; Ibrahim R; Albers BA; Camm AJ
    Europace; 2014 May; 16(5):626-30. PubMed ID: 24798956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.